National Institute of Dental & Craniofacial Research; Notice of Closed Meeting, 19495 [2020-07192]
Download as PDF
<![CDATA[
19495
Federal Register / Vol. 85, No. 67 / Tuesday, April 7, 2020 / Notices
Ending the HIV Epidemic: A Plan for
America (EHE), began in Fiscal Year
2020 and some of its data collection
requirements will be incorporated in
existing annual data collections,
including the ADR, in order to limit
recipient burden. Specifically, the
Recipient Report includes the following
proposed changes:
• Addition of two new ‘‘Yes/No’’
questions
• addition of one new follow-up
question that requests the number of
new clients enrolled
• addition of one question on funding
to monitor the use of funds provided to
ADAPs for the EHE initiative
• clarification on two existing
questions
• revision to one existing question
that requests program income and
manufacturer rebates reinvested in
ADAP, and
• deletion of six obsolete data
elements.
The Client Report includes the
following proposed changes:
• Revision to reporting of RWHAP
ADAP-funded medications to include
all medications rather than a subset of
medications;
• revision to one existing question
that requests reporting of all RWHAP
ADAP-funded medications using the
National Drug Code from the Drug
Identification Code (d-codes);
• revision to reporting of clinical data
for clients to include all clients rather
than a subset of clients; and
• deletion of three data elements that
were combined with other existing data
elements.
New and revised data elements
require reporting of information that
should already be collected by
recipients to meet legislative or
programmatic requirements for the
proper oversight and administration of
the program.
A 60-day notice was published in the
Federal Register on December 3, 2019,
vol. 84, No. 232; pp. 66202–03. There
were two public comments. Both
comments were requests to clarify the
data reporting changes, which included
requests for a copy of the ADR
instrument.
Need and Proposed Use of the
Information: HRSA’s RWHAP requires
the submission of annual reports by the
Secretary of Department of Health and
Human Services to the appropriate
committees of Congress. HRSA uses the
ADR to evaluate the national impact of
the HRSA RWHAP ADAP by providing
client-level data on individuals being
served, services being delivered, and
costs associated with these services. The
client-level data is used to monitor
health outcomes of people with HIV
receiving care and treatment through the
HRSA RWHAP ADAP, to monitor the
use of HRSA RWHAP ADAP funds in
addressing the HIV epidemic and its
impact on vulnerable communities, and
to track progress toward achieving the
goals identified in the National HIV/
AIDS Strategy.
Likely Respondents: State ADAPs of
RWHAP Part B recipients.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Form name
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
Recipient Report ..................................................................
Client-Level Report ..............................................................
54
54
1
1
54
54
6
81
324
4,374
Total ..............................................................................
* 54
........................
54
........................
4,698
Maria G. Button,
Director, Executive Secretariat.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2020–07247 Filed 4–6–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses
per
respondent
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
VerDate Sep<11>2014
18:22 Apr 06, 2020
Jkt 250001
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel NIDCR Secondary and
Genomic Data Analysis Application Review
Meeting.
Date: July 1, 2020.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Dental and
Craniofacial Research, National Institutes of
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
Health, 6701 Democracy Boulevard, Suite
668, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nisan Bhattacharyya,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute of Dental
and Craniofacial Research, National Institutes
of Health, 6701 Democracy Boulevard, Suite
668, Bethesda, MD 20892, 301–451–2405,
nisan_bhattacharyya@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: April 1, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–07192 Filed 4–6–20; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\07APN1.SGM
07APN1
]]>Agencies
[Federal Register Volume 85, Number 67 (Tuesday, April 7, 2020)]
[Notices]
[Page 19495]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-07192]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Dental & Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Dental and Craniofacial
Research Special Emphasis Panel NIDCR Secondary and Genomic Data
Analysis Application Review Meeting.
Date: July 1, 2020.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Dental and Craniofacial Research,
National Institutes of Health, 6701 Democracy Boulevard, Suite 668,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nisan Bhattacharyya, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Institute of Dental and
Craniofacial Research, National Institutes of Health, 6701 Democracy
Boulevard, Suite 668, Bethesda, MD 20892, 301-451-2405,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral
Diseases and Disorders Research, National Institutes of Health, HHS)
Dated: April 1, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-07192 Filed 4-6-20; 8:45 am]
BILLING CODE 4140-01-P
